Sanofi Exec On Go-To-Market Models, MLR Reviews, Ambidextrous Leadership

 
• By Anju Ghangurde

Sanofi’s EVP (general medicines), Olivier Charmeil, talks about pharma’s evolving go-to-market strategies that enmesh a more personalized, data-driven approach, why the medical, legal, and regulatory (MLR) review process needs to be faster and also impressive learnings from Amazon, Netflix and Ikea around building customer experience.

Sanofi Exec Talks About Evolving Go-To-Market Models

More from Scrip

More from Business